{"organizations": [], "uuid": "8e42d11325264bdfd8f19ac37464ad2d3c6328a0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180508.html", "section_title": "Archive News &amp; Video for Tuesday, 08 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-caredx-inc-enters-into-a-license-a/brief-caredx-inc-enters-into-a-license-and-commercialization-agreement-with-illumina-idUSFWN1SF1B3", "country": "US", "domain_rank": 408, "title": "BRIEF-Caredx Inc Enters Into A License And Commercialization Agreement With Illumina", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.616, "site_type": "news", "published": "2018-05-09T05:20:00.000+03:00", "replies_count": 0, "uuid": "8e42d11325264bdfd8f19ac37464ad2d3c6328a0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-caredx-inc-enters-into-a-license-a/brief-caredx-inc-enters-into-a-license-and-commercialization-agreement-with-illumina-idUSFWN1SF1B3", "ord_in_thread": 0, "title": "BRIEF-Caredx Inc Enters Into A License And Commercialization Agreement With Illumina", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "illumina", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-caredx inc", "sentiment": "negative"}, {"name": "caredx inc", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 8 (Reuters) - CareDx Inc:\n* CAREDX INC - ON MAY 4, 2018, CO ENTERED INTO A LICENSE AND COMMERCIALIZATION AGREEMENT WITH ILLUMINA, INC - SEC FILING\n* CAREDX-AGREEMENT PROVIDES CO WITH WORLDWIDE DISTRIBUTION, DEVELOPMENT, COMMERCIALIZATION RIGHTS TO ILLUMINA’S TRANSPLANT CLINICAL APPLICATION PRODUCTS\n* CAREDX-BEGINNING ON JUNE 1, CO WILL BE EXCLUSIVE WORLDWIDE DISTRIBUTOR OF ILLUMINA’S TRUSIGHT HLA V1 AND V2 PRODUCT LINES, ASSOCIATED ASSIGN HLA SOFTWARE\n* CAREDX INC - UNDER TERMS OF LICENSE AGREEMENT, COMPANY MADE A $5.0 MILLION INITIAL PAYMENT TO ILLUMINA\n* CAREDX - UNDER TERMS OF LICENSE AGREEMENT, COMPANY WILL PAY ROYALTIES IN MID-SINGLE TO LOW-DOUBLE DIGITS ON SALES OF FUTURE COMMERCIALIZED PRODUCTS Source text: ( bit.ly/2KLcJmR ) Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://bit.ly/2KLcJmR", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-09T05:20:00.000+03:00", "crawled": "2018-05-09T12:28:28.000+03:00", "highlightTitle": ""}